832 Results

People

  1. Pfister
    Pfister
  2. Lee
    Lee
  3. Sherman
    Sherman
  4. Riaz
    Riaz
  5. Dunn
    Dunn
  6. Wong
    Wong
  7. Ho
    Ho
  8. McBride
    McBride
  9. Shah
    Shah
  10. Tsai
    Tsai

Groups

  1. Head and Neck Service (832)
  2. Solid Tumor Oncology Division (832)
  3. Department of Medicine (826)
  4. Surgery (358)
  5. Radiation Oncology, Department of (310)
  6. Survivorship Research (310)
  7. Center for Pancreatic Cancer Research (173)
  8. Epidemiology and Biostatistics (162)
  9. Weinberg Fellows (161)
  10. Department of Pathology and Laboratory Medicine (155)
  1. "Head and Neck Service"
Formats
  1. Journal Article (407)
  2. Meeting Abstract (360)
  3. Book Section (20)
  4. Review (19)
  5. Editorial (7)
  6. Guidelines (7)
  7. Research Letter (6)
  8. Correspondence (3)
  9. Book Whole (1)
  10. Conference Paper (1)
  11. Miscellaneous (1)
Groups
  1. Head and Neck Service (832)
  2. Solid Tumor Oncology Division (832)
  3. Department of Medicine (826)
  4. Surgery (358)
  5. Radiation Oncology, Department of (310)
  6. Survivorship Research (310)

More Groups

People
  1. David Pfister (389)
  2. Eric Sherman (339)
  3. Nancy Lee (266)
  4. Alan Ho (238)
  5. Nadeem Riaz (159)
  6. Lara Dunn (141)

More People

Years
  1. 2025 (12)
  2. 2024 (72)
  3. 2023 (55)
  4. 2022 (57)
  5. 2021 (58)
  6. 2020 (66)

More Years

Publications
  1. Journal of Clinical Oncology (205)
  2. International Journal of Radiation Oncology, Biology, Physics (140)
  3. Annals of Oncology (43)
  4. Cancer (33)
  5. Head & Neck (28)
  6. Journal of the National Comprehensive Cancer Network (28)

More Publications

Publishers
  1. American Society of Clinical Oncology (219)
  2. Elsevier Inc. (176)
  3. Wiley Blackwell (55)
  4. Oxford University Press (53)
  5. American Association for Cancer Research (46)
  6. Harborside Press (28)

More Publishers

Results (832)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Tabelecleucel in combination with pembrolizumab (Pembro) in platinum-pretreated, recurrent/metastatic Epstein-Barr virus (EBV)-positive nasopharyngeal carcinoma (EBV plus NPC)
    Meeting Abstract

    Siu, L. L.; Bauml, J.; Adkins, D.; Colevas, A. D.; Perez, C. A.; Choe, J. H.; Zhang, Y.; Shi, W.; Navarro, W. H.; Haigentz, M.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Pilot study combining PD-L1 antibody durvalumab (D) with CTLA-4 antibody tremelimumab (T) and stereotactic body radiotherapy (SBRT) to treat metastatic anaplastic thyroid cancer (ATC)
    Meeting Abstract

    Sherman, E. J.; Tsai, C. J.; Zhi, W. I.; Fetten, J. V.; Wu, V.; Ho, A. L.; Riaz, N.; Pfister, D. G.; Lee, N. Y.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Biomarker predictors of outcome from a randomized trial of nivolumab +/- stereotactic body radiotherapy (SBRT) in metastatic (M1) head and neck squamous cell carcinoma (HNSCC)
    Meeting Abstract

    McBride, S. M.; Lee, N. Y.; Pfister, D. G.; Sherman, E. J.; Tsai, C. J.; Aghalar, J.; Eng, J.; Zhi, W. I.; McFarland, D. C.; Michel, L. S.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Ado-trastuzumab emtansine in patients with HER2 amplified salivary gland cancers (SGCs): Results from a phase II basket trial
    Meeting Abstract

    Li, B. T.; Shen, R.; Offin, M.; Buonocore, D. J.; Myers, M. L.; Venkatesh, A.; Razavi, P.; Ginsberg, M. S.; Ulaner, G. A.; Solit, D. B.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Alliance A091404: A phase II study of enzalutamide (NSC# 766085) for patients with androgen receptor-positive salivary cancers
    Meeting Abstract

    Ho, A. L.; Foster, N. R.; Zoroufy, A. J.; Worden, F. P.; Andress, K.; Price, R.; Adkins, D.; Bowles, D. W.; Kang, H.; Burtness, B.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Phase 2 study of cemiplimab, a human monoclonal anti-PD-1, in patients (pts) with metastatic cutaneous squamous cell carcinoma (mCSCC; Group 1): 12-month follow-up
    Meeting Abstract

    Guminski, A. D.; Lim, A. M. L.; Khushalani, N. I.; Schmults, C. D.; Hernandez-Aya, L. F.; Modi, B.; Dunn, L.; Hughes, B. G. M.; Chang, A. L. S.; Hauschild, A.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • ACCURACY: Phase (P) 2 trial of AL101, a pan-Notch inhibitor, in patients (pts) with recurrent/metastatic (R/M) adenoid cystic carcinoma (ACC) with Notch activating mutations (Notch(act mut))
    Meeting Abstract

    Ferrarotto, R.; Ho, A. L.; Wirth, L. J.; Dekel, E.; Walker, R. W.; Vergara-Silva, A. L.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Phase I and expanded access experience of LOXO-195 (BAY 2731954), a selective next-generation TRK inhibitor (TRKi)
    Meeting Abstract

    Hyman, D.; Kummar, S.; Farago, A.; Geoerger, B.; Mau-Sorensen, M.; Taylor, M.; Garralda, E.; Nagasubramanian, R.; Natheson, M.; Song, L.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Mechanism of action of the farnesyltransferase inhibitor, tipifarnib, and its clinical applications
    Meeting Abstract

    Gualberto, A.; Scholz, C.; Mishra, V.; Janes, M. R.; Kessler, L.; Van Cutsem, E.; Ho, A. L.; Witzig, T.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Salvage surgery for recurrent larynx cancer
    Journal Article

    Mimica, X.; Hanson, M.; Patel, S. G.; McGill, M.; McBride, S.; Lee, N.; Dunn, L. A.; Cracchiolo, J. R.; Shah, J. P.; Wong, R. J.; more...
    Head & Neck (2019)

    Fulltext@MSK | Save